While for overall survival (OS), high expression of TRPV3 in KIRC, TRPV2 and TRPV4 in UVM, TRPV5 in PCPG led to prolonged survival, and for progression-free survival (PFS), high expression of TRPV3 in KIRC, TRPV2 and TRPV4 in UVM, TRPV1 in PRAD may be associated with a better survival (P < 0.05, Figure 1D). This evidence concerns the gene TRPV4 and prostate adenocarcinoma.